저온 멸균 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 장비별, 지역별, 부문별 예측(2025-2030년)

Low Temperature Sterilization Market Growth & Trends:

The global low temperature sterilization market size is anticipated to reach USD 5.07 billion by 2030 and is anticipated to expand at a CAGR of 10.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of HAIs is expected to drive demand for low-temperature sterilization solutions in the coming years, as these sterilizers effectively sanitize medical instruments like thermometers and endoscopes. According to data published by the WHO in May 2022, out of every 100 patients in acute-care healthcare settings such as hospitals, 15 in low- and middle-income nations and 7 in high-income countries will develop at least one HAI during their hospital visit and stay. Furthermore, on average, 1 in 10 patients affected by HAI may die. This increasing prevalence of HAIs is expected to increase the focus on infection control and prevention, further boosting the future demand for low-temperature sterilization methods.

The increasing popularity of vaporized hydrogen peroxide sterilization is anticipated to boost market growth in the coming years. Supportive government rules and regulations for this sterilization technique are expected to boost the demand for low-temperature sterilizers that use vaporized hydrogen peroxide sterilization methods. For instance, in January 2024, Vaporized Hydrogen Peroxide (VHP), a low-temperature sterilization technique, was approved by the FDA to sterilize medical devices. With this authorization, the agency facilitated broader adoption of VHP as a sterilization technique for the medical device industry. Such approvals from the regulatory authorities for vaporized hydrogen peroxide are anticipated to boost the market growth in the coming years.

The market is expected to grow in the coming years due to technological advancements. For instance, in March 2024, Getinge introduced a low-temperature sterilization system called Poladus 150, designed for sterilizing heat-sensitive surgical instruments. This system features advanced cross-contamination barrier technology and helps prevent HAII. Moreover, it is compatible with FleetView, a lifecycle management tool, and T-DOC, a sterile supply management software. The increasing connectivity and instrument traceability, along with the launch of technologically advanced products by industry players, are anticipated to drive market growth in the future.

Low Temperature Sterilization Market Report Highlights:

• Ethylene oxide sterilizers dominated the product segment with more than 50.01% share in 2024 owing to their ability to effectively sterilize a wide range of heat- and moisture-sensitive medical devices that cannot withstand traditional high-temperature steam sterilization.
• The hydrogen peroxide sterilizers segment is expected to grow at the fastest CAGR over the forecast period.
• The endoscopes dominated the device type segment in 2024 owing to their increasing prevalence of minimally invasive surgeries and diagnostic procedures, which rely heavily on these instruments.
• North America dominated the low temperature sterilization market owing to the advanced healthcare infrastructure, stringent regulatory frameworks, and the growing demand for infection control measures in hospitals & healthcare facilities.
• Market players operating in low temperature sterilization market include ASP Global (Fortive Corporation), Getinge, STERIS, Stryker, TDK Corporation, 3M, Steelco S.p.A., Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.), DE LAMA S.P.A., Genist Technocracy Pvt. Ltd., Andersen Sterilizers, Labotronics Scientific, Labtron Equipment Ltd, Qingdao Antech Scientific Co., Ltd., Renosem, Scitek Global Co., Ltd., SOLSTEO, Sterile Safequip And Chemicals LLP, Tuttnauer, HUMAN MEDITEK CO., LTD., MMM Group, Canon Singapore Pte. Ltd., INSTECH SYSTEMS, Biobase Biodusty (Shandong), Co., Ltd., Telstar (Azbil Group), Shinva Medical Instrument Co., Ltd.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Device
  • 1.2.3. Regional Scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Low Temperature Sterilization Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Developments in Medical Devices
    • 3.2.1.2. Increasing Investment for Sterilization Devices and Infrastructure
    • 3.2.1.3. Expansion Into Emerging Economies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risks and Complications Associated With Different Sterilization Methods
• 3.3. Low Temperature Sterilization Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Low Temperature Sterilization Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 4.1. Low Temperature Sterilization Market: Product Outlook and Key Takeaways
• 4.2. Low Temperature Sterilization Market: Product Movement Analysis
• 4.3. Low Temperature Sterilization Market Estimates & Forecast, by Product (USD Million)
• 4.4. Ethylene Oxide Sterilizers
  • 4.4.1. Ethylene Oxide Sterilizers Market, 2018 - 2030 (USD Million)
  • 4.4.2. Hydrogen Peroxide Sterilizers
    • 4.4.2.1. Hydrogen Peroxide Sterilizers Market, 2018 - 2030 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Low Temperature Sterilization Market - Segment Analysis, by Device, 2018 - 2030 (USD Million)

• 5.1. Low Temperature Sterilization Market: Device Outlook and Key Takeaways
• 5.2. Low Temperature Sterilization Market: Device Movement Analysis
• 5.3. Low Temperature Sterilization Market Estimates & Forecast, by Device Type (USD Million)
• 5.4. Endoscopes
  • 5.4.1. Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.4.2. Flexible Endoscopes
    • 5.4.2.1. Flexible Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.2.2. Single-Channel Flexible Endoscopes
      • 5.4.2.2.1. Single-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.2.3. Dual-Channel Flexible Endoscopes
      • 5.4.2.3.1. Dual-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.2.4. Triple-Channel Flexible Endoscopes
      • 5.4.2.4.1. Triple-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.4.3. Rigid Endoscopes
    • 5.4.3.1. Rigid Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.3.2. Single-Channel Rigid Endoscopes
      • 5.4.3.2.1. Single-Channel Rigid Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.3.3. Dual-Channel Rigid Endoscopes
      • 5.4.3.3.1. Dual-Channel Rigid Endoscopes Market, 2018 - 2030 (USD Million)
• 5.5. Laparoscopy Kit
  • 5.5.1. Laparoscopy Kit Market, 2018 - 2030 (USD Million)
• 5.6. Ophthalmology
  • 5.6.1. Ophthalmology Market, 2018 - 2030 (USD Million)
• 5.7. Otolaryngology (ORL)
  • 5.7.1. Otolaryngology (ORL) Market, 2018 - 2030 (USD Million)
• 5.8. Other Instruments
  • 5.8.1. Other Instruments Market, 2018 - 2030 (USD Million)

Chapter 6. Low Temperature Sterilization Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Recent Developments & Impact Analysis by Key Market Participants
• 7.3. Company Market Share Analysis, 2024
• 7.4. Key Company Profiles
  • 7.4.1. ASP Global (Fortive Corporation)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Getinge
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. STERIS
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Stryker
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. TDK Corporation
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. 3M
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Steelco S.p.A.
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.)
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. DE LAMA S.P.A.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Genist Technocracy Pvt. Ltd.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Andersen Sterilizers
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Labotronics Scientific
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Labtron Equipment Ltd
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Qingdao Antech Scientific Co., Ltd.
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. Renosem
    • 7.4.15.1. Company overview
    • 7.4.15.2. Financial performance
    • 7.4.15.3. Product benchmarking
    • 7.4.15.4. Strategic initiatives
  • 7.4.16. Scitek Global Co., Ltd.
    • 7.4.16.1. Company overview
    • 7.4.16.2. Financial performance
    • 7.4.16.3. Product benchmarking
    • 7.4.16.4. Strategic initiatives
  • 7.4.17. SOLSTEO
    • 7.4.17.1. Company overview
    • 7.4.17.2. Financial performance
    • 7.4.17.3. Product benchmarking
    • 7.4.17.4. Strategic initiatives
  • 7.4.18. Sterile Safequip And Chemicals Llp
    • 7.4.18.1. Company overview
    • 7.4.18.2. Financial performance
    • 7.4.18.3. Product benchmarking
    • 7.4.18.4. Strategic initiatives
  • 7.4.19. Tuttnauer
    • 7.4.19.1. Company overview
    • 7.4.19.2. Financial performance
    • 7.4.19.3. Product benchmarking
    • 7.4.19.4. Strategic initiatives
  • 7.4.20. HUMAN MEDITEK CO., LTD.
    • 7.4.20.1. Company overview
    • 7.4.20.2. Financial performance
    • 7.4.20.3. Product benchmarking
    • 7.4.20.4. Strategic initiatives
  • 7.4.21. MMM Group
    • 7.4.21.1. Company overview
    • 7.4.21.2. Financial performance
    • 7.4.21.3. Product benchmarking
    • 7.4.21.4. Strategic initiatives
  • 7.4.22. Canon Singapore Pte. Ltd.
    • 7.4.22.1. Company overview
    • 7.4.22.2. Financial performance
    • 7.4.22.3. Product benchmarking
    • 7.4.22.4. Strategic initiatives
  • 7.4.23. INSTECH SYSTEMS
    • 7.4.23.1. Company overview
    • 7.4.23.2. Financial performance
    • 7.4.23.3. Product benchmarking
    • 7.4.23.4. Strategic initiatives
  • 7.4.24. Biobase Biodusty (Shandong), Co., Ltd.
    • 7.4.24.1. Company overview
    • 7.4.24.2. Financial performance
    • 7.4.24.3. Product benchmarking
    • 7.4.24.4. Strategic initiatives
  • 7.4.25. Telstar (Azbil Group)
    • 7.4.25.1. Company overview
    • 7.4.25.2. Financial performance
    • 7.4.25.3. Product benchmarking
    • 7.4.25.4. Strategic initiatives
  • 7.4.26. Shinva Medical Instrument Co., Ltd.
    • 7.4.26.1. Company overview
    • 7.4.26.2. Financial performance
    • 7.4.26.3. Product benchmarking
    • 7.4.26.4. Strategic initiatives